Copyright Reports & Markets. All rights reserved.

Global Hydrocortisone Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hydrocortisone Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Intramuscular Injection
    • 1.3.3 Intravenous Drip
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hydrocortisone Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinics
    • 1.4.4 Other
  • 1.5 Global Hydrocortisone Injection Market Size & Forecast
    • 1.5.1 Global Hydrocortisone Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Hydrocortisone Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Hydrocortisone Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Hydrocortisone Injection Product and Services
    • 2.1.4 Pfizer Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 KINGYOR
    • 2.2.1 KINGYOR Details
    • 2.2.2 KINGYOR Major Business
    • 2.2.3 KINGYOR Hydrocortisone Injection Product and Services
    • 2.2.4 KINGYOR Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 KINGYOR Recent Developments/Updates
  • 2.3 Jiangsu Kangbao Pharmaceutical
    • 2.3.1 Jiangsu Kangbao Pharmaceutical Details
    • 2.3.2 Jiangsu Kangbao Pharmaceutical Major Business
    • 2.3.3 Jiangsu Kangbao Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.3.4 Jiangsu Kangbao Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Jiangsu Kangbao Pharmaceutical Recent Developments/Updates
  • 2.4 Hebei Tiancheng Pharmaceutical
    • 2.4.1 Hebei Tiancheng Pharmaceutical Details
    • 2.4.2 Hebei Tiancheng Pharmaceutical Major Business
    • 2.4.3 Hebei Tiancheng Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.4.4 Hebei Tiancheng Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Hebei Tiancheng Pharmaceutical Recent Developments/Updates
  • 2.5 CSPC Ouyi Pharmaceutical
    • 2.5.1 CSPC Ouyi Pharmaceutical Details
    • 2.5.2 CSPC Ouyi Pharmaceutical Major Business
    • 2.5.3 CSPC Ouyi Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.5.4 CSPC Ouyi Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
  • 2.6 Shiyao YINHU Pharmaceutical
    • 2.6.1 Shiyao YINHU Pharmaceutical Details
    • 2.6.2 Shiyao YINHU Pharmaceutical Major Business
    • 2.6.3 Shiyao YINHU Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.6.4 Shiyao YINHU Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Shiyao YINHU Pharmaceutical Recent Developments/Updates
  • 2.7 Dalian Holley Kingkong Pharmaceutical
    • 2.7.1 Dalian Holley Kingkong Pharmaceutical Details
    • 2.7.2 Dalian Holley Kingkong Pharmaceutical Major Business
    • 2.7.3 Dalian Holley Kingkong Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.7.4 Dalian Holley Kingkong Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Dalian Holley Kingkong Pharmaceutical Recent Developments/Updates
  • 2.8 Jiangsu Lianhuan Pharmaceutical
    • 2.8.1 Jiangsu Lianhuan Pharmaceutical Details
    • 2.8.2 Jiangsu Lianhuan Pharmaceutical Major Business
    • 2.8.3 Jiangsu Lianhuan Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.8.4 Jiangsu Lianhuan Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
  • 2.9 Anhui Chengshi Pharmaceutical
    • 2.9.1 Anhui Chengshi Pharmaceutical Details
    • 2.9.2 Anhui Chengshi Pharmaceutical Major Business
    • 2.9.3 Anhui Chengshi Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.9.4 Anhui Chengshi Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Anhui Chengshi Pharmaceutical Recent Developments/Updates
  • 2.10 Anhui Changjiang Pharmaceutical
    • 2.10.1 Anhui Changjiang Pharmaceutical Details
    • 2.10.2 Anhui Changjiang Pharmaceutical Major Business
    • 2.10.3 Anhui Changjiang Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.10.4 Anhui Changjiang Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Anhui Changjiang Pharmaceutical Recent Developments/Updates
  • 2.11 Maanshan Fengyuan Pharmaceutical
    • 2.11.1 Maanshan Fengyuan Pharmaceutical Details
    • 2.11.2 Maanshan Fengyuan Pharmaceutical Major Business
    • 2.11.3 Maanshan Fengyuan Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.11.4 Maanshan Fengyuan Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Maanshan Fengyuan Pharmaceutical Recent Developments/Updates
  • 2.12 BIOZEN Pharmaceutical
    • 2.12.1 BIOZEN Pharmaceutical Details
    • 2.12.2 BIOZEN Pharmaceutical Major Business
    • 2.12.3 BIOZEN Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.12.4 BIOZEN Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 BIOZEN Pharmaceutical Recent Developments/Updates
  • 2.13 Hubei Zhongjiachem Pharmaceutical
    • 2.13.1 Hubei Zhongjiachem Pharmaceutical Details
    • 2.13.2 Hubei Zhongjiachem Pharmaceutical Major Business
    • 2.13.3 Hubei Zhongjiachem Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.13.4 Hubei Zhongjiachem Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Hubei Zhongjiachem Pharmaceutical Recent Developments/Updates
  • 2.14 HUAZHONG Pharmaceutical
    • 2.14.1 HUAZHONG Pharmaceutical Details
    • 2.14.2 HUAZHONG Pharmaceutical Major Business
    • 2.14.3 HUAZHONG Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.14.4 HUAZHONG Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 HUAZHONG Pharmaceutical Recent Developments/Updates
  • 2.15 Southwest Pharmaceutical
    • 2.15.1 Southwest Pharmaceutical Details
    • 2.15.2 Southwest Pharmaceutical Major Business
    • 2.15.3 Southwest Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.15.4 Southwest Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Southwest Pharmaceutical Recent Developments/Updates
  • 2.16 Chengdu No.1 Pharmaceutical
    • 2.16.1 Chengdu No.1 Pharmaceutical Details
    • 2.16.2 Chengdu No.1 Pharmaceutical Major Business
    • 2.16.3 Chengdu No.1 Pharmaceutical Hydrocortisone Injection Product and Services
    • 2.16.4 Chengdu No.1 Pharmaceutical Hydrocortisone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Chengdu No.1 Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Hydrocortisone Injection by Manufacturer

  • 3.1 Global Hydrocortisone Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Hydrocortisone Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Hydrocortisone Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Hydrocortisone Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Hydrocortisone Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Hydrocortisone Injection Manufacturer Market Share in 2025
  • 3.5 Hydrocortisone Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Hydrocortisone Injection Market: Region Footprint
    • 3.5.2 Hydrocortisone Injection Market: Company Product Type Footprint
    • 3.5.3 Hydrocortisone Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hydrocortisone Injection Market Size by Region
    • 4.1.1 Global Hydrocortisone Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Hydrocortisone Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Hydrocortisone Injection Average Price by Region (2021-2032)
  • 4.2 North America Hydrocortisone Injection Consumption Value (2021-2032)
  • 4.3 Europe Hydrocortisone Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Hydrocortisone Injection Consumption Value (2021-2032)
  • 4.5 South America Hydrocortisone Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Hydrocortisone Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Hydrocortisone Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Hydrocortisone Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Hydrocortisone Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Hydrocortisone Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Hydrocortisone Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Hydrocortisone Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Hydrocortisone Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Hydrocortisone Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Hydrocortisone Injection Market Size by Country
    • 7.3.1 North America Hydrocortisone Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Hydrocortisone Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Hydrocortisone Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Hydrocortisone Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Hydrocortisone Injection Market Size by Country
    • 8.3.1 Europe Hydrocortisone Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Hydrocortisone Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hydrocortisone Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Hydrocortisone Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Hydrocortisone Injection Market Size by Region
    • 9.3.1 Asia-Pacific Hydrocortisone Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Hydrocortisone Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Hydrocortisone Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Hydrocortisone Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Hydrocortisone Injection Market Size by Country
    • 10.3.1 South America Hydrocortisone Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Hydrocortisone Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hydrocortisone Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Hydrocortisone Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Hydrocortisone Injection Market Size by Country
    • 11.3.1 Middle East & Africa Hydrocortisone Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Hydrocortisone Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Hydrocortisone Injection Market Drivers
  • 12.2 Hydrocortisone Injection Market Restraints
  • 12.3 Hydrocortisone Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hydrocortisone Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hydrocortisone Injection
  • 13.3 Hydrocortisone Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hydrocortisone Injection Typical Distributors
  • 14.3 Hydrocortisone Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hydrocortisone Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Hydrocortisone Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hydrocortisone Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hydrocortisone Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hydrocortisone Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hydrocortisone Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hydrocortisone Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hydrocortisone Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, KINGYOR, Jiangsu Kangbao Pharmaceutical, Hebei Tiancheng Pharmaceutical, CSPC Ouyi Pharmaceutical, Shiyao YINHU Pharmaceutical, Dalian Holley Kingkong Pharmaceutical, Jiangsu Lianhuan Pharmaceutical, Anhui Chengshi Pharmaceutical, Anhui Changjiang Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hydrocortisone Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Intramuscular Injection
    Intravenous Drip
    Market segment by Application
    Hospital
    Clinics
    Other
    Major players covered
    Pfizer
    KINGYOR
    Jiangsu Kangbao Pharmaceutical
    Hebei Tiancheng Pharmaceutical
    CSPC Ouyi Pharmaceutical
    Shiyao YINHU Pharmaceutical
    Dalian Holley Kingkong Pharmaceutical
    Jiangsu Lianhuan Pharmaceutical
    Anhui Chengshi Pharmaceutical
    Anhui Changjiang Pharmaceutical
    Maanshan Fengyuan Pharmaceutical
    BIOZEN Pharmaceutical
    Hubei Zhongjiachem Pharmaceutical
    HUAZHONG Pharmaceutical
    Southwest Pharmaceutical
    Chengdu No.1 Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hydrocortisone Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hydrocortisone Injection, with price, sales quantity, revenue, and global market share of Hydrocortisone Injection from 2021 to 2026.
    Chapter 3, the Hydrocortisone Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hydrocortisone Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Hydrocortisone Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hydrocortisone Injection.
    Chapter 14 and 15, to describe Hydrocortisone Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now